Responsiveness differences in outcome instruments after revision hip arthroplasty: What are the implications?

BMC Musculoskeletal Disorders

Jasvinder A Singh¹ 

[1] Medicine Service, Birmingham VA Medical Center and Department of Medicine, University of Alabama, Birmingham, AL, USA

关键词: HHS;    SF-36;    short-form 36;    harris hip score;    hip arthroplasty;    Responsiveness;   

Others  :  1158476
DOI  :  10.1186/1471-2474-12-107

 received in 2011-05-06, accepted in 2011-05-23,  发布年份 2011

【 摘 要 】

Responsiveness to change is an important psychometric property of an outcome instrument. Assessment of health-related quality of life (HRQoL) is critical to outcome assessment after total joint replacement, a surgery aimed at improving pain, function and HRQoL of the patients undergoing these procedures. In a recent study, Shi et al. examined the responsiveness to change of various subscales of two instruments, physician-administered Harris Hip Score and patient self-administered Short Form-36 (SF-36), 6 months after revision total hip arthroplasty. The responsiveness statistics for both scales were reasonable, higher for Harris Hip Score than SF-36. This is the first study to examine responsiveness of these instruments in revision THA patients in a systematic fashion.

【 授权许可】

   
2011 Singh; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Gershon RC, Rothrock N, Hanrahan R, Bass M, Cella D: The use of PROMIS and assessment center to deliver patient-reported outcome measures in clinical research. J Appl Meas 2010, 11(3):304-14.
• [2]Riddle DL, Stratford PW, Bowman DH: Findings of extensive variation in the types of outcome measures used in hip and knee replacement clinical trials: a systematic review. Arthritis Rheum 2008, 59(6):876-83.
• [3]Shi HY, Chang JK, Wong CY, Wang JW, Tu YK, Chiu HC, et al.: Responsiveness and minimal important differences after revision total hip arthroplasty. BMC Musculoskelet Disord 2010, 11:261. BioMed Central Full Text
• [4]Blanchard C, Feeny D, Mahon JL, Bourne R, Rorabeck C, Stitt L, et al.: Is the Health Utilities Index responsive in total hip arthroplasty patients? Journal of Clinical Epidemiology 2003, 56(11):1046-54. [Comparative Study Research Support, Non-U.S. Gov't]
• [5]Hoeksma HL, Van den Ende CHM, Ronday HK, Heering A, Breedveld FC, Dekker J: Comparison of the responsiveness of the Harris Hip Score with generic measures for hip function in osteoarthritis of the hip. Annals of the Rheumatic Diseases 2003, 62(10):935-8.
• [6]Angst F, Aeschlimann A, Steiner W, Stucki G: Responsiveness of the WOMAC osteoarthritis index as compared with the SF-36 in patients with osteoarthritis of the legs undergoing a comprehensive rehabilitation intervention. Ann Rheum Dis 2001, 60(9):834-40.
• [7]Soohoo NF, Vyas RM, Samimi DB, Molina R, Lieberman JR: Comparison of the responsiveness of the SF-36 and WOMAC in patients undergoing total hip arthroplasty. J Arthroplasty 2007, 22(8):1168-73.
• [8]Cohen J: A power primer. Psychol Bull 1992., 112(155-9)
• [9]Kane RL, Saleh KJ, Wilt TJ, Bershadsky B: The functional outcomes of total knee arthroplasty. J Bone Joint Surg Am 2005, 87(8):1719-24.
• [10]Gioe TJ, Pomeroy D, Suthers K, Singh JA: Can patients help with long-term total knee arthroplasty surveillance? Comparison of the American Knee Society Score self-report and surgeon assessment. Rheumatology (Oxford) 2009, 48(2):160-4.
• [11]Quintana JM, Escobar A, Bilbao A, Arostegui I, Lafuente I, Vidaurreta I: Responsiveness and clinically important differences for the WOMAC and SF-36 after hip joint replacement. Osteoarthritis Cartilage 2005, 13(12):1076-83.
• [12]Escobar A, Quintana JM, Bilbao A, Arostegui I, Lafuente I, Vidaurreta I: Responsiveness and clinically important differences for the WOMAC and SF-36 after total knee replacement. Osteoarthritis Cartilage 2007, 15(3):273-80.
• [13]Singh J, Sloan JA, Johanson NA: Challenges with health-related quality of life assessment in arthroplasty patients: problems and solutions. J Am Acad Orthop Surg 2010, 18(2):72-82.
• [14]Riddle DL, Stratford PW, Singh JA, Strand CV: Variation in outcome measures in hip and knee arthroplasty clinical trials: a proposed approach to achieving consensus. J Rheumatol 2009, 36(9):2050-6.